FDA data Registry peer set 3 peers

Alternatives to ertugliflozin

3 same-class SPL records vs ertugliflozin - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Steglatro

SGLT2 Inhibitor Prescription 3 alternatives found

3 SGLT2 Inhibitor peers (wide set)

Compare ertugliflozin vs canagliflozin side-by-side →

ertugliflozin vs canagliflozin & dapagliflozin · FAERS reaction fields

FAERS top-reaction field "Diabetic Ketoacidosis" shows the widest count spread between ertugliflozin and canagliflozin, dapagliflozin, empagliflozin in this extract (3,722-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect ertugliflozin canagliflozindapagliflozinempagliflozin
Nausea 86 997 2,218 3,212
Urinary Tract Infection 62 1,016 1,265 1,814
Vomiting 59 - 1,621 2,399
Fungal Infection 58 1,446 1,352 2,057
Diabetic Ketoacidosis 51 3,421 1,524 3,773
Blood Glucose Increased 46 1,227 1,861 3,043
Dizziness 46 839 2,096 2,417
Diarrhoea 43 770 2,074 2,806

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

ertugliflozin peer mix vs class inventory

Peer mix

0 OTC and 3 Rx SPL records in this peer set (3 total). Class inventory for SGLT2 Inhibitor: 4 drugs.

Frequently Asked Questions

What same-class SPL records sit beside ertugliflozin?
This registry lists 3 SGLT2 Inhibitor medication records beside ertugliflozin, including canagliflozin, dapagliflozin, empagliflozin. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide SGLT2 Inhibitor peer set (3 records)

ertugliflozin (Steglatro) sits in a wide SGLT2 Inhibitor peer set (3 of 3 class peers shown).

Top FAERS reaction fields for ertugliflozin total 505 reports across 10 reactions, set beside canagliflozin, dapagliflozin, empagliflozin. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full ertugliflozin profile →

Field note for ertugliflozin: see also the generic vs brand label guide when reading Steglatro SPL strings.